Literature DB >> 9813060

Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states.

D Jiang1, H Yang, J K Willson, J Liang, L E Humphrey, E Zborowska, D Wang, J Foster, R Fan, M G Brattain.   

Abstract

CBS human colon carcinoma cells are poorly tumorigenic in athymic nude mice, whereas FET colon carcinoma cells are non-tumorigenic. Both cell lines have well differentiated properties in tissue culture. Transforming growth factor alpha (TGF-alpha) was ectopically expressed by stable transfection of a TGF-alpha cDNA under repressible tetracycline control. The TGF-alpha-transfected cells showed enhanced clonal initiation and shortened lag phase growth in tissue culture without an alteration in doubling time in exponential phase relative to untransfected cells. Furthermore, the TGF-alpha transfectants showed increased independence from exogenous growth factors in clonal growth assays and induction of DNA synthesis after release from quiescence. Growth factor independence was associated with sustained epidermal growth factor receptor activation in quiescent TGF-alpha-transfected cells and the requirement of exogenous insulin for stimulation of quiescent cells to re-enter the cell cycle. Higher cloning, reduced lag time in tissue, and the acquisition of growth factor independence for DNA synthesis without a change in doubling time of TGF-alpha-transfected cells indicate that autocrine TGF-alpha functions by facilitating re-entry into the cell cycle from sub-optimal growth states rather than promoting or controlling the proliferation of actively cycling cells. The modulation of growth regulation by autocrine TGF-alpha was associated with increased malignant properties as TGF-alpha transfectants showed increased tumorigenicity in athymic nude mice. The administration of tetracycline reversed the effects of TGF-alpha expression in these cells both in vivo and in vitro, indicating that the alterations of the biological properties were due to the expression of TGF-alpha. Since these cells are continuously grown in a completely chemically defined medium without serum supplementation, it was possible to assign the mechanism underlying the generation of growth factor independence to the replacement of a requirement for exogenous insulin in parental cells by autocrine TGF-alpha.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813060     DOI: 10.1074/jbc.273.47.31471

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor.

Authors:  Yi Peter Hu; Sandip B Patil; Michelle Panasiewicz; Wenhui Li; Jennie Hauser; Lisa E Humphrey; Michael G Brattain
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

2.  The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer.

Authors:  Chandrakanth Are; Neka Simms; Ashwani Rajput; Ashwani Rajupt; Michael Brattain
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

3.  Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis.

Authors:  I Zucchi; E Mento; V A Kuznetsov; M Scotti; V Valsecchi; B Simionati; E Vicinanza; G Valle; S Pilotti; R Reinbold; P Vezzoni; A Albertini; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-17       Impact factor: 11.205

4.  Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model.

Authors:  Takamitsu Sasaki; Toru Nakamura; Robert B Rebhun; Hua Cheng; Katherine Stemke Hale; Rachel Z Tsan; Isaiah J Fidler; Robert R Langley
Journal:  Am J Pathol       Date:  2008-07       Impact factor: 4.307

5.  Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.

Authors:  Xinhua Chen; Johannes Fruehauf; Jeffrey D Goldsmith; Hua Xu; Kianoosh K Katchar; Hon-Wai Koon; Dezheng Zhao; Efi G Kokkotou; Charalabos Pothoulakis; Ciarán P Kelly
Journal:  Gastroenterology       Date:  2009-05-29       Impact factor: 22.682

6.  The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis.

Authors:  Maged W Helmy; Asser I Ghoneim; Mohamed A Katary; Rana K Elmahdy
Journal:  Mol Biol Rep       Date:  2020-02-22       Impact factor: 2.316

Review 7.  Autocrine stimulation in colorectal carcinoma (CRC): positive autocrine loops in human colorectal carcinoma and applicable significance of blocking the loops.

Authors:  Wen-Jing Ruan; Mao-De Lai
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

8.  Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.

Authors:  Neka A K Simms; Ashwani Rajput; Elizabeth A Sharratt; Melanie Ongchin; Carol A Teggart; Jing Wang; Michael G Brattain
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

9.  Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines.

Authors:  Sanjib Chowdhury; Melanie Ongchin; Elizabeth Sharratt; Ivan Dominguez; Jing Wang; Michael G Brattain; Ashwani Rajput
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

10.  Differential PKA activation and AKAP association determines cell fate in cancer cells.

Authors:  Erik D Hedrick; Ekta Agarwal; Premila D Leiphrakpam; Katie L Haferbier; Michael G Brattain; Sanjib Chowdhury
Journal:  J Mol Signal       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.